# OnCo record actithera (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/actithera/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "actithera" ;
  schema:name "Actithera"@en ;
  schema:description "Actithera designs small radioactive drugs that stick to a protein found around many solid tumours (FAP) and stay there longer, so more of the radiation reaches the cancer. Its first medicine was being prepared for human trials in 2026."@en ;
  schema:url <https://onco.cc/companies/actithera/>, <https://actithera.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://actithera.com/>, <https://actithera.com/wp-content/uploads/2025/07/250709-Actithera-Series-A-PR-Final.pdf>, <https://www.biopharmadive.com/news/actithera-radiopharmaceutical-cancer-series-a/752493/>, <https://actithera.com/recent-news-press/> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/> ;
  onco:targets <https://onco.cc/targets/fap/> .